VHsquared Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 2010-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.vhsquared.com
Clinical Trials
12
Active:8
Completed:4
Trial Phases
2 Phases
Phase 1:10
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
Phase 1
10 (83.3%)Phase 2
2 (16.7%)Open-label V565 Target Engagement Study
Phase 1
Completed
- Conditions
- Ulcerative Colitis
- First Posted Date
- 2018-10-15
- Last Posted Date
- 2018-10-15
- Lead Sponsor
- VHsquared Ltd.
- Target Recruit Count
- 5
- Registration Number
- NCT03705117
- Locations
- 🇬🇧
The Royal London Hospital, London, United Kingdom
A First Time in Human Study in Healthy Volunteers and Patients
- First Posted Date
- 2017-01-05
- Last Posted Date
- 2017-01-05
- Lead Sponsor
- VHsquared Ltd.
- Target Recruit Count
- 47
- Registration Number
- NCT03010787
- Locations
- 🇬🇧
Quintiles Drug Research Unit at Guy's Hospital, Quintiles Ltd, London, United Kingdom
A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease
- First Posted Date
- 2016-11-29
- Last Posted Date
- 2021-12-22
- Lead Sponsor
- VHsquared Ltd.
- Target Recruit Count
- 125
- Registration Number
- NCT02976129
- Locations
- 🇺🇸
Advanced Research Center, Inc., Anaheim, California, United States
🇺🇸West Central Gastroenterology, Clearwater, Florida, United States
🇺🇸Clinical Research of West Florida, Clearwater, Florida, United States
News
No news found